| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |